Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
McGill University
$27,000.00
Understanding the epigenetic basis of the transition from complete hydatidiform mole to choriocarcinoma
FY 2025-26
Summary
The placenta is the organ necessary to sustain the life of the fetus during pregnancy. In some pregnancies, a fetus does not develop and the placenta grows abnormally, forming a mass of tissue in the uterus called a complete hydatidiform mole. Although initially benign, the mass can develop into cancer, termed choriocarcinoma, before invading surrounding maternal tissues. While most cancers can be attributed to changes in the sequence of DNA, choriocarcinoma is not. Instead, it develops through chemical modifications on DNA, which affect which genes are turned on or off. My goal is to investigate these changes to better understand how choriocarcinoma develops. To do so, I will use advanced genetic techniques to investigate how the chemical modifications of DNA differ between healthy placenta, hydatidiform moles and choriocarcinoma. Next, I will perturb the protein responsible for depositing these chemical modifications in order to determine which DNA regions are being targeted specifically in choriocarcinoma. Identification of these DNA regions will uncover novel therapeutic targets to aid in the treatment of choriocarcinoma patients.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572596
Name
Larsen Olivia
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding the epigenetic basis of the transition from complete hydatidiform mole to choriocarcinoma
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cancer; Carcinogenesis; Cellular Differentiation; Choriocarcinoma; Complete Hydatidiform Mole; Dna Methylation; Epigenetics; Genetics; Placenta; Trophoblast Stem Cells
Abstract
The placenta is the organ necessary to sustain the life of the fetus during pregnancy. In some pregnancies, a fetus does not develop and the placenta grows abnormally, forming a mass of tissue in the uterus called a complete hydatidiform mole. Although initially benign, the mass can develop into cancer, termed choriocarcinoma, before invading surrounding maternal tissues. While most cancers can be attributed to changes in the sequence of DNA, choriocarcinoma is not. Instead, it develops through chemical modifications on DNA, which affect which genes are turned on or off. My goal is to investigate these changes to better understand how choriocarcinoma develops. To do so, I will use advanced genetic techniques to investigate how the chemical modifications of DNA differ between healthy placenta, hydatidiform moles and choriocarcinoma. Next, I will perturb the protein responsible for depositing these chemical modifications in order to determine which DNA regions are being targeted specifically in choriocarcinoma. Identification of these DNA regions will uncover novel therapeutic targets to aid in the treatment of choriocarcinoma patients.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Larsen, Olivia
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~